Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FLVCR1 antisense RNA 1 (FLVCR1-DT) is a long noncoding RNA gene located adjacent to the protein-coding FLVCR1 gene, which encodes a heme transporter involved in erythropoiesis and neuronal function[2][5][6]. FLVCR1-DT itself is noncoding and presumed to act through regulatory RNA mechanisms, possibly influencing FLVCR1 gene expression, splicing, or chromatin structure. While FLVCR1-DT is sometimes referenced alongside FLVCR1 due to its genomic proximity and antisense orientation, it is not a transporter, receptor, enzyme, or protein, and thus not considered a direct therapeutic target. Most functional studies and disease associations relate to the FLVCR1 protein rather than FLVCR1-DT; however, antisense and divergent transcripts often play roles in molecular regulation or disease through modulation of nearby genes. As of now, no direct biological function, disease mechanism, drug interaction, or biomarker status has been established for FLVCR1-DT itself[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FLVCR1 antisense RNA 1 (FLVCR1-DT).